Today, I'm looking at two small-cap technology groups that are expanding through a mix of acquisitions and market share growth.
Strong underlying gains
When a company is going through a major period of change, adjusted accounts showing only continuing operations can be very useful for investors. These numbers provide a snapshot of progress that strips out all the 'noise'.
Commentators often tell us not to try to time the market as many failed traders will tell you this is an almost impossible task. Although I totally agree with this advice, I personally believe we should still try to do our utmost to buy quality stocks at the best possible price. So today I'm looking at two smaller London-listed firms whose strong upward share price momentum seems to have paused for breath in recent months, perhaps signalling a buying opportunity for new investors.
Although revenues and profits at Cohort (LSE:CHRT) remain under pressure, I am confident that its long-term earnings picture remains solid.
The defence giant advised Wednesday that revenues dipped 10% in the six months to October, to £44.8m, while adjusted operating profit ducked 8% year-on-year to £3.6m. On top of this, it said order intake fell to £39.2m from £40.5m previously, and that its closing order book was down to £132.1m from £136.5m.